Disclosure Of First-Time Adoption [Text Block]

Mithra Pharmaceuticals S.A. - Filing #3183078

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
33,687,000 EUR
19,934,000 EUR
396,254,000 EUR
41,228,000 EUR
408,647,000 EUR
336,633,000 EUR
2,545,000 EUR
340,769,000 EUR
33,840,000 EUR
32,250,000 EUR
219,759,000 EUR
332,535,000 EUR
31,271,000 EUR
13,690,000 EUR
157,737,000 EUR
Comprehensive income
- EUR
18,298,000 EUR
77,918,000 EUR
59,620,000 EUR
- EUR
17,300,000 EUR
- EUR
- EUR
134,175,000 EUR
116,875,000 EUR
Profit (loss)
59,620,000 EUR
59,620,000 EUR
116,875,000 EUR
116,875,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.